Fortis Healthcare · NSE: FORTIS · BSE: 532843

Q3 FY20 results · Oct–Dec 2019

Fortis Healthcare reported revenue from operations of ₹1,168.92 crore (up 6.0% from Q3 FY19) and net loss of ₹69.32 crore for Q3 FY20 (Oct–Dec 2019), on a consolidated basis.

Consolidated · ₹ crore
Item	Q3 FY20	Q3 FY19	YoY	Q2 FY20	QoQ
Revenue from operations	1,168.92	1,103.27	+6.0%	1,212.17	−3.6%
Other income	4.92	43.24	−88.6%	9.75	−49.5%
Total income	1,173.84	1,146.51	+2.4%	1,221.92	−3.9%
Profit before share of associates & JVs and tax	43.98	(217.54)	Turned profit	126.59	−65.3%
Share of profit/(loss) of associates & JVs	4.16	17.00		3.16
Net profit for the period	(69.32)	(180.11)	Loss narrowed	124.04	Turned loss
Attributable to shareholders of the company	(76.34)	(197.07)	Loss narrowed	110.98	Turned loss
EPS, basic (₹)	(1.01)	(3.06)	Loss narrowed	1.47	Turned loss
Net margin (%)	-5.9	-16.3		10.2

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q3 FY20	Q3 FY19	YoY	Q2 FY20	QoQ
Revenue from operations	173.86	—	—	181.40	−4.2%
Other income	58.10	—	—	147.99	−60.7%
Total income	231.96	—	—	329.39	−29.6%
Profit before tax	10.67	—	—	21.14	−49.5%
Net profit for the period	46.40	—	—	(13.27)	Turned profit
EPS, basic (₹)	0.61	—	—	(0.17)	Turned profit
Net margin (%)	26.7	—		-7.3

Consolidated

Filed with BSE: 15 Feb 2020, 10:31 IST
Board meeting: 14 Feb 2020
Period: 01 Oct 2019 to 31 Dec 2019
Review status: Unaudited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 15 Feb 2020, 10:31 IST
Board meeting: 14 Feb 2020
Period: 01 Oct 2019 to 31 Dec 2019
Review status: Unaudited
Source: XBRL filing on BSE